Hangzhou Tigermed Consulting News

Tiger Pharmaceuticals: Legal Opinion of Beijing Jiayuan Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hangzhou Tiger Pharmaceutical Technology Co., Ltd.

Oct 8 18:34

Tiger Pharmaceuticals: A Comparative Table of Regulations Revision (October 2024)

Oct 8 18:34

Tiger Pharmaceuticals: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Oct 8 18:34

Tiger Pharmaceuticals: Announcement on foreign investment and related transactions

Sep 28 00:00

Tiger Pharmaceuticals: Announcement on additional pledges for shareholders holding 5% or more of the shares

Sep 27 17:02

Tiger Pharmaceuticals: Announcement on the holding of the 3rd Extraordinary General Meeting of Shareholders in 2024

Sep 14 00:00

Tiger Pharmaceuticals: Announcement on the “Double Improvement of Quality and Return” Action Plan

Aug 29 17:38

Tiger Pharmaceuticals: Board of Directors Rules of Procedure

Aug 29 00:00

Tiger Pharmaceuticals: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024

Aug 29 00:00

Tiger Pharmaceuticals: A Comparative Table of Regulations Amendments (August 2024)

Aug 29 00:00

Hangzhou Tigermed Consulting: Announcement regarding the holding subsidiary providing guarantees for other holding subsidiaries.

Jul 24 15:56

Tiger Pharmaceuticals: Announcement on the normal production and operation of the company

Jun 14 16:16

Hangzhou Tigermed Consulting: Legal Opinions of Beijing Jiayuan Law Firm on the 2023 Annual General Meeting of Shareholders of Hangzhou Tiger Pharmaceutical Technology Co., Ltd., the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024

May 24 20:49

Hangzhou Tigermed Consulting: Announcement of the resolutions of the 2023 Annual General Meeting of Shareholders, the 2024 Second Class A Shareholders' Meeting, and the 2024 Second Class H Shareholders' Meeting

May 24 20:49

Hangzhou Tigermed Consulting: Legal opinions of the 2024 Second Extraordinary General Meeting of Shareholders, the 2024 First Class A Shareholders' Meeting, and the 2024 First Class H Shareholders' Meeting

Apr 30 19:08

Hangzhou Tigermed Consulting: Notice to creditors on cancellation of repurchased shares, capital reduction and addition of repurchased shares

Apr 30 19:08

Hangzhou Tigermed Consulting: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders, the 2024 First Class A Shareholders' Meeting, and the 2024 First Class H Shareholders' Meeting

Apr 30 19:08

Hangzhou Tigermed Consulting: Announcement on holding the 2023 Annual General Meeting of Shareholders, the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024

Apr 30 00:00

Tiger Pharmaceuticals: Announcement on the cancellation of some proposals and the addition of temporary proposals and supplementary notices at the 2024 Second Extraordinary General Meeting of Shareholders, the 2024 First Class A Shareholders' Meeting, and

Apr 13 00:00

Tiger Pharmaceuticals: Announcement on the holding of the 2nd Extraordinary General Meeting of Shareholders in 2024, the 1st Class A Shareholders' Meeting in 2024, and the 1st Class H Shareholders' Meeting in 2024

Apr 10 00:00